| Mrs Jessica W Federman, | |
|
25 West Independence Way, Suite I, Kingston, RI 02881 | |
| (401) 874-9387 | |
| (401) 874-4404 |
| Full Name | Mrs Jessica W Federman |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 25 West Independence Way, Kingston, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043860406 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SP01511 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Jessica W Federman, 25 West Independence Way, Suite I, Kingston, RI 02881 Ph: (401) 874-9387 | Mrs Jessica W Federman, 25 West Independence Way, Suite I, Kingston, RI 02881 Ph: (401) 874-9387 |
News Archive
Using new MRI techniques to analyze tissue composition and structure in the brain, researchers from the University of Pennsylvania School of Medicine and the National Institute on Aging successfully detected mild cognitive disorder (MCI), a condition in which patients suffer mild memory problems and is often an early symptom of Alzheimer's disease (AD).
In resource-limited settings where tuberculosis is a major cause of mortality among HIV patients and where a multidrug-resistant TB epidemic is emerging, researchers are pressing for approaches to integrate TB prevention and treatment into HIV care and treatment.
Ferring Pharmaceuticals Inc. today announced publication of one of its pivotal Phase 3 trials of LYSTEDA (tranexamic acid) tablets for cyclic heavy menstrual bleeding in the October issue of the peer-reviewed journal, Obstetrics & Gynecology. The six-month clinical trial demonstrated that LYSTEDA significantly reduced menstrual blood loss from baseline, and improved health-related quality-of-life parameters in women with cyclic HMB while maintaining safety and tolerability.
In patients with non-ST-elevation acute coronary syndrome (NSTE- ACS), pre-treatment with the P2Y12 antagonist prasugrel prior to catheterization, significantly increases the risk of life-threatening bleeding without reducing the risk of major ischemic events, according to the results of the ACCOAST (A Comparison of Prasugrel at PCI or Time of Diagnosis of Non-ST Elevation Myocardial Infarction) trial.
Beckman Coulter has launched two automated systems in the UK to ease rapidly increasing workloads in microbiology and virology departments. The DxN VERIS Molecular Diagnostics system, for same-day molecular viral load testing, and the MicroScan Microbiology Systems for microorganism identification (ID) and antimicrobial susceptibility testing (AST), both rapidly and accurately identify therapeutic pathways for patient management.
› Verified 7 days ago
Deborah A. November, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 25 W Independence Way Ste I, Kingston, RI 02881 Phone: 401-874-5969 | |
Patricia Babigian Rendine, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 25 W Independence Way, Kingston, RI 02881 Phone: 401-874-2577 | |
Constance Gelfuso, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 25 W Independence Way, Suite I, Kingston, RI 02881 Phone: 401-874-9385 Fax: 401-874-4404 | |
Geraldine Theodore, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 25 W Independence Way, Suite I, Kingston, RI 02881 Phone: 401-874-2577 Fax: 401-874-4404 | |
Uri Speech And Hearing Center Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 25 W Independence Way Ste I, Kingston, RI 02881 Phone: 401-874-9387 | |
Christie Johnson, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 25 W Independence Way, Kingston, RI 02881 Phone: 401-789-4614 |